Pauline Dürr



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Identification of diagnosis-related contraindications based on the medication plan alone (2022) Andrikyan W, Then M, Gaßmann KG, Tuemena T, Dürr P, Fromm M, Maas R Conference contribution A LC-HRMS method for drug exposure measurement of 57 oral anticancer drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap (2022) Andrikyan W, Then M, Gaßmann KG, Tuemena T, Dürr P, Fromm M, Maas R Journal article Ökonomische Aspekte bei der Versorgung von Patient*innen mit neuen oralen Tumortherapeutika: Erkenntnisse aus der AMBORA-Studie (2022) Dürr P, Schlichtig K, Krebs S, Schramm A, Schötz L, Fromm M, Dörje F Journal article An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma (2021) Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study (2021) Schlichtig K, Dürr P, Dörje F, Fromm M Journal article